Anaplastic thyroid cancer evolved from papillary carcinoma: Demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 1, 2003, Pages 96-100

  Wiseman, Sam M ^a   Loree, Thom R ^a   Hicks Jr , Wesley L ^a   Rigual, Nestor R ^a   Winston, Janet S ^a   Tan, Donfeng ^a   Anderson, Garth R ^a   Stoler, Daniel L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; REPETITIVE DNA;

AGED; ANAPLASTIC CARCINOMA; ARTICLE; CARCINOGENESIS; CASE REPORT; CELL DIFFERENTIATION; CELL POPULATION; CELL TRANSFORMATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOPRESERVATION; DNA EXTRACTION; DYSPHAGIA; EVALUATION; EVOLUTION; FEMALE; GENOME ANALYSIS; HISTOPATHOLOGY; HOARSENESS; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; POLYMERASE CHAIN REACTION; TECHNIQUE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TISSUE SECTION; TUMOR CELL; TUMOR LOCALIZATION;

EID: 0037225071     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.1.96     Document Type: Article

References (34)

1. Basik M, Stoler DL, Kontzoglou KC, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR. Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysis. Genes Chromosomes Cancer. 1997;18:19-29.
2. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A. 1999;96:15121-15126.
3. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997;79:564-573.
4. McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028-1034.
5. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. Anaplastic carcinoma of the thyroid: a clinicopathologic study of 121 cases. Cancer. 1990;66:321-330.
6. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery. 1991;110:956-961; discussion 961-963.
7. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma: a study of 70 cases. Am J Clin Pathol. 1985;83:135-158.
8. Passler C, Scheuba C, Prager G, et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC): a retrospective analysis. Langenbecks Arch Surg. 1999;384:284-293.
9. Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999;16:64-69.
10. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol. 1992;18:83-88.
11. Nilsson O, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg. 1998;22:725-730.
12. Hadar T, Mor C, Shvero J, Levy R, Segal K. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol. 1993;19:511-516.
13. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg. 2001;25:617-622.
14. Lu WT, Lin JD, Huang HS, Chao TC. Does surgery improve the survival of patients with advanced anaplastic thyroid carcinoma? Otolaryngol Head Neck Surg. 1998;118:728-731.
15. Lam KL, Lo C, Chan K, Wan K. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg. 2000;231:329-338.
16. Kobayashi T, Asakawa H, Umeshita K, et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck. 1996;18:36-41.
17. Voutilainen PE, Multanen M, Haapiainen RK, Leppaniemi AK, Sivula AH. Anaplastic thyroid carcinoma survival. World J Surg. 1999;123:975-978; discussion 978-979.
18. Lo C, Lam K, Wan K. Anaplastic carcinoma of the thyroid. Am J Surg. 1999;177:337-339.
19. Tan RK, Finley RK III, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck. 1995;17:41-47; discussion 47-48.
20. Haigh PI, Ituarte PH, Wu HS. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001;91:2335-2342.
21. Rodriguez JM, Pinero A, Ortiz S, et al. Clinical and histological differences in anaplastic thyroid carcinoma. Eur J Surg. 2000;166:34-38.
22. Spires JR, Schwartz MR, Miller RH. Anaplastic thyroid carcinoma: association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 1988;114:40-44.
23. Ibanez ML, Russell WO, Albores-Saavedra J, Lampertico P, White EC, Clark RL. Thyroid carcinoma-biologic behavior and mortality: postmortem findings in 42 cases, including 27 in which the disease was fatal. Cancer. 1966;19:1039-1052.
24. Nishiyama RH, Dunn EL, Thompson NW. Anaplastic spindle-cell and giant-cell tumors of the thyroid gland. Cancer. 1972;30:113-127.
25. Aldinger KA, Samaan NA, Ibanez M, Hill CS Jr. Anaplastic carcinoma of the thyroid: a review of 84 cases of spindle and giant cell carcinoma of the thyroid. Cancer. 1978;141:2267-2275.
26. Saunders CA, Nayar R. Anaplastic spindle-cell squamous carcinoma arising in association with tall-cell papillary cancer of the thyroid: a potential pitfall. Diagn Cytopathol. 1999;21:413-418.
27. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, Pierotti MA. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol. 1994;172:337-342.
28. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol. 2000;13:882-887.
29. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML, Rimm DL. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma. Cancer Res. 1999;59:1811-1815.
30. Hoang-Vu C, Dralle H, Scheumann G, et al. Gene expression of differentiation and dedifferentiation markers in normal and malignant human thyroid tissues. Exp Clin Endocrinol. 1992;100:51-56.
31. Zou M, Shi Y, al-Sedairy S, Farid NR. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer. 1993;68:385-388.
32. Stringer BM, Rowson JM, Parkar MH, et al. Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas. Experientia. 1989;45:372-376.
33. Zietkiewicz E, Rafalski A, Labuda D. Genome fingerprinting by simple sequence repeat (SSR)-anchored polymerase chain reaction amplification. Genomics. 1994;20:176-183.
34. Stoler DL, Datta RV, Charles MA, et al. Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck. 2002;24:290-295.